Antibodies: Engineering & Therapeutics

Antibodies: Engineering and Therapeutics

Antibody engineering has become a well-developed discipline, encompassing discovery methods, production strategies, and modification techniques that have brought forth clinically investigated and marketed therapeutics. The realization of the long-standing goal of production of fully human monoclonal antibodies has focused intensive research on the clinical employment of this potent drug category. The latest research is going on the basic biology of antibodies and on the development, function and future of therapeutic antibodies.

  • Monoclonal antibodies
  • Antibody-Based Drugs
  • Antibody-targeted fusion proteins for cancer therapy
  • Antibodies: Engineering Technologies
  • Antibodies: Medical Applications
  • Antibody Drug Therapy
  • Antibody-mediated disorders

Related Conference of Antibodies: Engineering & Therapeutics

September 01-02, 2017

4th International Conference on Parasitology

Prague, Czech Republic
November 2-3, 2017

9th World Congress and Expo on Immunology

Atlanta, Georgia, USA
November 02-03, 2017

9th World Congress on Immunity, Inflammation and Immunotherapies

Atlanta, Georgia, USA
November 06-07, 2017

2nd International Conference on Autoimmunity

Frankfurt, Germany
November 08-09, 2017

3rd Antibodies and Bio Therapeutics Congress & B2B

Las Vegas, Nevada, USA
November 13-14, 2017

5th International Conference on HIV/AIDS, STDs and STIs

Las Vegas, Nevada, USA
Dec 14-15, 2017

World Immunology Congress

Dubai, UAE

9th European Immunology Conference

June 14-16, 2018 Rome, Italy

Antibodies: Engineering & Therapeutics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in